We previously screened the genomic patterns of several RTKs (EGFR, HER2, MET, FGFR2, and IGF1R) in a panel of 49 GC cell lines, and HER2 amplification was observed in six cell lines21. This evidence concerns the gene FGFR2 and gastric cancer.